Several studies have identified Bmi‐1 protein overexpression in various human cancers, including prostate cancer [24], lymphoma [25], multiple myeloma [26], and primary neuroblastoma [27], and it has been considered a marker of poor prognosis. The gene discussed is BMI1; the disease is cancer.